Greetings
My name is Kirshner Ross-Vaden RN and I am the Vice President of the Foreign Patient Division of Beike Bio-tech and their lead medical consultant. Umbilical Cord Stem Cells and their clinical applications are my area of expertise and personal passion. I have been in the medical field since the mid 1980's and have been working with stem cell therapy since 2004. My home base is the United States but I also travel throughout China as part of my job. I have been asked to write an introduction to readers about Beike which is a bio-tech company based in China. It is my hope that you find this informative and educational.
Welcome to Beike
As a company on the leading edge of medical technology we are dedicated to developing and providing safe, effective treatments utilizing Umbilical Cord Blood derived Stem Cell Therapy. We partner with top ranked hospitals across the globe, leading scientists and doctors. Our mission is to be the world leader in stem cell research. We pride ourselves in the customization and personalization of development and research as well as clinical care. The goal of our company is to make comprehensive cellular therapy widely available, accessible to those in need and as cost effective as possible. Beike has developed treatment programs that are effective for a wide array of health issues and has to date provided stem cell transplants to well over 2500 patients from around the world. Beike Bio-tech is considered by many to be the largest and most reputable company in the industry of clinical cellular therapy. Having successfully performed over 10,000 stem cell transplants since incorporating in 2005 we are clearly leading the way in this fast paced area combining science, technology, medicine, and personal attention to improve the quality of life for both children and adults alike.
Company History
Beike (pronounced Bay-Ka) is a bio-technology company based in China with its head offices located in Shenzhen. We were originally founded with capital from Beijing University, Hong Kong University of Science and Technology and Shenzhen City Hall. In addition the formation of the company was also supported with grants from the China State National Fund. The research and clinical applications were developed over a period of several years beginning back in the late 1990's. The work was a collaboration of Beijing University, Hong Kong University of Science and Technology, No. 3 Army Medical University, Zhongshan Medical University, Guiyang Medical College and Zhengzhou University. During this period and throughout all its collaborating laboratories Beike had over sixty Ph.D. researchers focusing on developing effective and safe stem cell products designed for wide clinical use. In 2001 the research based group to become known as Beike was given the go ahead by the Chinese governmental medical oversight department to proceed with treating patients. The company was incorporated in January of 2005 after the collaborating scientists felt comfortable enough with their years of research and clinical experience to begin treating patients with stem cells on a commercial scale.
Our Labs
Beike's main research labs are located in Shenyang, Shenzhen and Zhengzhou. We partner with the government blood banks in these cities. Beike bio-tech obtains its prescreened cord blood directly from the government blood banks. There are many points that set us apart from all other stem cell companies but this is a major one that should be noted. We at Beike process our own cellular products from start to finish. These stem cells are literally in the hands of our own personnel every step of the way. This ensures the highest quality of product available and maintains a direct responsibility and thus reliability on the part of our company.
Beike's Cells
Beike utilizes Umbilical Cord Stem Cells and Autologous (self) Bone Marrow Stem Cells only. Our Umbilical Cord Stem Cell transfusions consist of three subsets of stem cells known as CD34+, CD133 and Mesenchymal stem cells. CD34+ and CD133 have been shown in numerous studies to be prone towards becoming white matter which is what neural cells and myelin are made of. Mesenchymals have been found to be inclined to be become numerous types of cells including but not limited to chondrocytes (a type of cell critical to tissue renewal particularly cartilage), muscle and neurons. They also appear to be able to conduct repairs in relation to vascular disorders within the brain, ocular areas and throughout the body. Our bone marrow transplants utilize the patients own bone marrow. From this we culture out 3 subsets of stem cells in two separate culturings. The first culture yields both Hematopoietic Cells (MNC) and Endothelial Progenitor Cells (EPC). The second culture yields pure Mesenchymal stem cells.
Our Treatment Approach
Our treatment approach is a holistic one. We not only provide patients with stem cell transplants but we also put each patient into a complete custom tailored rehabilitation program. Typically treatment includes several stem cell transfusions of 10 to 15 million stem cells each over a 20 to 30 day period with rehabilitation approximately 6 days per week. With each Stem Cell Transplant we also give the patients a transfusion of Neural Growth Factors and Cord Serum to encourage the stem cells to find their targets and transform into new neurons. The stem cells are transfused into the patients via the bloodstream with Intravenous Transfusions and into the Cerebral Spinal Fluid via a lumbar procedure where the cells and growth factors are directly injected into the spinal canal. In addition we also offer our clients the opportunity to have a Bone Marrow Transplant during their stay. This involves removing the patients own bone marrow, culturing, expanding and purifying the stem cells from it and then transfusing it back into the patient.
Our complementary rehabilitation program consists of a tailored mix of Physical Therapy, Occupational Therapy, Speech Therapy, Acupuncture, Electronic Muscle Stimulation (EMS), Functional Manipulation, ADL (Activities of Daily Life) education and Chinese massage. It is this holistic approach combined with the incredible power of the Stem Cells, Serum and Neural Growth Factors that gives our clients the best chance for improvements. We have performed over 10,000 procedures, have a zero treatment related infection rate, hold a zero surgical complication rate and an across the board an 86% improvement percentage reported by our patients and shown in post treatment evaluations.
You can e-mail Kirshner with any questions at Kirshner.ross@gmail.com
Written by:
Kirshner Ross-Vaden
5/27/08